MARC details
000 -LEADER |
fixed length control field |
07814cam a2200433 i 4500 |
001 - CONTROL NUMBER |
control field |
19578944 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
KENaKMTC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20221219105334.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
170331s2017 ne a b 001 0 eng c |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2017285066 |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
101703700 |
Source |
DNLM |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780128040034 |
Qualifying information |
(hardcover) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0128040033 |
Qualifying information |
(hardcover) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)ocn992502407 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
NLM |
Language of cataloging |
eng |
Transcribing agency |
DLC |
Description conventions |
rda |
Modifying agency |
YDX |
-- |
OCLCO |
-- |
BDX |
-- |
BTCTA |
-- |
QGQ |
-- |
OCLCF |
-- |
OCLCA |
-- |
BUF |
-- |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC269.5 |
Item number |
.A36 2017 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
2017 C-488 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QZ 203 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
362.19699/4 |
Edition number |
23 |
245 00 - TITLE STATEMENT |
Title |
Introduction to cancer metastasis / |
Statement of responsibility, etc |
edited by Aamir Ahmad, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, United States. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Amsterdam |
Name of publisher, distributor, etc |
Elsevier |
Date of publication, distribution, etc |
c2017 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xii, 403 pages : |
Other physical details |
illustrations (some color) ; |
Dimensions |
24 cm |
490 1# - SERIES STATEMENT |
Series statement |
Cancer metastasis ; |
Volume number/sequential designation |
volume 1 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
List of contributors -- Preface -- I CANCER METASTASIS FROM PRIMARY ORGANS -- 1 CANCER METASTASIS: AN INTRODUCTION -- 1. Introduction -- 2. Disruption of Cell Adhesion: Initiation of Metastasis -- 3. Matrix Metalloproteinases in Cancer Metastasis -- 4. EMT in Cancer Metastasis -- 5. Organ-Specific Metastasis -- 6. microRNAs and Cancer Stem Cells in Cancer Metastasis -- 7. Conclusions and Perspectives -- 2. BREAST CANCER METASTASIS -- 1. Introduction -- 2. Biology -- 3. Metastatic Dissemination -- 4. Prognostic Factors After Recurrence -- 5. Treatment for Metastatic Breast Cancer -- 6. Conclusions -- 3. PROSTATE CANCER METASTASIS -1. Epidemiology and Overview of Metastatic Prostate Cancer -- 2. Cellular Biology of Prostate Cancer Metastases -- 3. The Metastatic Cascade -- 4. Conclusions -- 4. LUNG CANCER METASTASIS -- 1. General Information -- 2. Mechanism of Metastasis -- 3. Molecular Mechanism in the Regulation of Lung Cancer Metastasis -- 4. Epithelial to Mesenchymal Transition in Lung Cancer -- 5. Cancer Stem Cells -- 6. Concluding Remarks -- 5. CERVICAL CANCER METASTASIS -- 1. Introduction -- 2. Risk Factors -- 3. Pathogenesis -- 4. Histopathology -- 5. Routes of Dissemination -- 6. Major Molecular Factors -- 7. Conclusion -- 6. COLORECTAL CANCER METASTASIS -- 1. Introduction -- 2. Molecular Aspects of Colorectal Cancer Metastasis -- 3. Main Sites of Colorectal Cancer Metastasis -- 4. Therapeutic Options for Metastatic Colorectal Cancer -- 5. Challenges and Probable Solutions -- 6. Conclusions -- 7. METASTATIC PANCREATIC CANCER: CURRENT STATE AND FUTURE DIRECTIONS -- 1 Introduction -- 2 Management of pancreatic ductal adenocarcinoma -- 3 Molecular mechanisms driving metastasis -- 4 In vivo experimental models -- 5 Open question: onset and dynamics of metastasis -- 6 Conclusions -- 8 GASTRIC CANCER METASTASIS -- 1 Epidemiology and screening programs -- 2 Metastatic GC -- clinical aspects -- 3 Diagnosis of metastatic GC with a particular focus on 18-F-FDG PET/CT -- 4 Prognostic and predictive factors -- 5 Biomarkers -- 6 Treatment methods of metastatic GC -- 7 Conclusion -- 9 HEPATOCELLULAR CARCINOMA: METASTATIC DISEASE -- 1 Introduction -- 2 Epidemiology -- 3 Diagnosis -- 4 Prognosis and staging -- 5 Treatment -- 6 Conclusions -- 10 METASTATIC BLADDER CANCER -- 1 Introduction -- 2 Epidemiology -- 3 Staging -- 4 Grading -- 5 Staging tools -- 6 Emerging biomarkers -- 7 Prognostic factors -- 8 Clinical presentation of metastatic bladder disease -- 9 Management of clinically localized bladder cancer, positive pelvic nodes and metastatic disease -- 10 Clinical prognosticators -- 11 Management of metastatic bladder cancer -- 12 New agents -- 13 Immunotherapy -- 14 Role of surgery in metastatic bladder cancer -- 15 Conclusions -- 11 METASTATIC CUTANEOUS SQUAMOUS CELL CARCINOMAS -- 1 Introduction -- 2 Defining the high-risk variant -- 3 Staging systems -- 4 Treating high-risk cutaneous squamous cell carcinoma -- 5 Sentinel node biopsy -- 6 Treatment of locally advanced or metastatic cutaneous squamous cell carcinoma -- 7 Concluding remarks -- 12 OSTEOSARCOMA METASTASIS-PROGNOSTIC FACTORS AND TREATMENT STRATEGIES -- 1 Introduction -- 2 Clinical features of metastasis from osteosarcoma -- 3 Treatment for metastasis from osteosarcoma -- 4 Conclusion -- II CANCER METASTASIS TO DISTANT ORGANS -- 13 LYMPH NODE METASTASIS -- 1 Introduction -- 2 History -- 3 Mechanisms-how tumors metastasize to lymph nodes -- 4 Clinical aspects of lymph node metastasis -- 5 Pathology -- 6 Conclusions and summary -- 14 MOLECULAR INVOLVEMENT OF THE BONE MARROW MICROENVIRONMENT IN BONE METASTASIS -- 1 Introduction -- 2 Types of bone metastasis -- 3 Pathophysiology of bone metastasis -- 4 Treatment options for bone metastasis -- 5 Discussion/conclusion -- 15 AN OVERVIEW ON HEPATIC METASTASIS -- 1 Introduction -- 2 Hepatic physiology and cancer biology -- 3 Hepatic functional and surgical anatomy -- 4 Clinical presentation and diagnosis -- 5 Treatment of hepatic metastasis -- 6 Conclusions -- 16 PULMONARY METASTASIS -- 1 Development of pulmonary metastasis -- 2 Rationale for local treatment of pulmonary metastases -- 3 Diagnosis of pulmonary metastases -- 4 Preoperative exams -- 5 Surgical resection -- 6 Radiological ablation -- 7 Radiotherapy -- 8 Lymph node involvement -- 9 Resection of recurrent metastases -- 10 Lung metastasis in given tumor types -- 11 Conclusion -- 17 BRAIN METASTASIS: BASIC BIOLOGY, CLINICAL MANAGEMENT, AND INSIGHT FROM EXPERIMENTAL MODEL SYSTEMS -- 1 Introduction -- 2 Biology -- 3 Clinical management -- 4 Experimental model systems -- 5 Preclinical findings -- 6 Conclusions -- III EMERGING TARGETS FOR CANCER METASTASIS -- 18 DEVELOPMENTAL PATHWAYS: EMERGING THERAPEUTIC TARGETS FOR CANCER METASTASIS -- 1 Introduction -- 2 Prometastatic changes and developmental pathways -- 3 Notch signaling and metastasis -- 4 Antimetastatic potential of Wnt and hedgehog targeting -- 5 Concluding remarks -- 19 EMERGING THERAPEUTIC TARGETS FOR CANCER METASTASIS: FROM THE PERSPECTIVE OF EMBRYO IMPLANTATION -- 1 Introduction -- 2 The similarity between embryo implantation and tumor metastasis -- 3 Trophoblast invasion inhibitory factors derived from the maternal endometrium during embryo implantation and their implications in cancer metastasis -- 4 Conclusions and perspectives -- 20 WNT SIGNALING AS A THERAPEUTIC TARGET IN CANCER AND METASTASIS -- 1 Introduction -- 2 Wnt signaling and cancer -- 3 The role of Wnt signaling in epithelial-mesenchymal transition and cancer stem cells -- 4 Therapeutic strategies targeting Wnt signaling -- 5 Protein knockdown strategies -- 6 Viral-based therapies -- 7 Conclusion -- Index |
520 0# - SUMMARY, ETC. |
Summary, etc |
"Introduction to Cancer Metastasis provides an overview of cancer metastais and novel therapeutic targets, all in one place. Through specific chapters on three divers topics - primary cancers and their metastasis, common metastatic sites and emerging targets for therapy - this volume comprehensively informs readers on the broader knowledge gained on cancer metastasis so far. Key features: Includes basic biology and translational approaches to organ-specific cancer sites; Provides readers with information on emerging therapeutic targets for cancer metastasis; Contains contributions from leading researchers around the globe"--P. [4] of cover. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Metastasis. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Neoplasm Metastasis. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer. |
Source of heading or term |
fast |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Metastasis. |
Source of heading or term |
fast |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Ahmad, Aamir, |
Relator term |
editor. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Cancer metastasis (2017) ; |
Volume number/sequential designation |
v. 1. |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
pccadap |
d |
2 |
e |
ncip |
f |
20 |
g |
y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Library of Congress Classification |
Koha item type |
Books |
Intials |
LL |